Somatostatin in inflammatory bowel disease
Intestinal inflammation is controlled by various immunomodulating cells, interacting by molecular mediators. Neuropeptides, released by enteric nerve cells and neuroendocrine mucosa cells, are able to affect several aspects of the general and intestinal immune system, with both pro- as well as anti-...
Saved in:
Main Authors: | J. D. Van Bergeijk (Author), J. H. P. Wilson (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
1997-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Somatostatin does not attenuate intestinal injury in dextran sodium sulphate-induced subacute colitis
by: J. D. van Bergeijk, et al.
Published: (1998) -
Leukocyte migration in experimental inflammatory bowel disease
by: E. P. Van Rees, et al.
Published: (1997) -
Cytokines in inflammatory bowel disease
by: P. L. Beck, et al.
Published: (1997) -
Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells
by: Valentina Rossi, et al.
Published: (2019) -
The effect of malotilate, a derivative of malotilate and a flavenoid on eicosanoid production in inflammatory bowel disease in rats
by: A. P. M. van Dijk, et al.
Published: (1993)